Come up with a name for your new list and we'll add to it:
Amydis Diagnostics raised a round of funding on October 09, 2017. Investors include
National Institutes of Health.
Amydis is a privately-held pharmaceutical company focused on developing chemistry to detect diseases that involve the presence of amyloid proteins. The company's mission is to develop a universal, non…